Healthcare PR - May 2010
20 May 2010 | by Claire Murphy
How the success of the dementia lobby is inspiring other groups representing health conditions. Plus - essay writers consider how comms can aid the NHS overhaul.
As pharma companies negotiate the prospect of a fundamentally changed NHS and a new drug pricing system, our writers look for the threats and opportunities of the new landscape. Plus - interview with GSK's v-p, global comms, Phil Thomson.
How the success of the dementia lobby is inspiring other groups representing health conditions. Plus - essay writers consider how comms can aid the NHS overhaul.
How hospitals' PR teams have fought back against C-Difficile. Plus - the challenge of reaching doctors online